537 results on '"Sterman, Daniel H."'
Search Results
2. Low-field MRI lung opacity severity associated with decreased DLCO in post-acute Covid-19 patients
3. Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma
4. Pleural fluid microbiota as a biomarker for malignancy and prognosis
5. Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma
6. Asbestosis
7. Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome
8. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype
9. A PROSPECTIVE, MULTICENTER EVALUATION OF SAFETY AND DIAGNOSTIC OUTCOMES WITH ROBOTIC-ASSISTED BRONCHOSCOPY: RESULTS FROM THE TARGET TRIAL
10. Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013.
11. SAFETY RESULTS FROM MULTI-CENTER OBSERVATIONAL REAL-WORLD ROBOTIC BRONCHOCOPY (TARGET) STUDY
12. PULMONARY TUBERCULOSIS OR ORGANIZING PNEUMONIA: A CASE OF EMPIRIC TREATMENT FOR THE WRONG DISEASE
13. IMPACTS ON MANAGEMENT OF HIGH-RISK LUNG NODULES AND PATIENT OUTCOMES AFTER VIRTUAL REVIEW BY A MULTIDISCIPLINARY LUNG NODULE REVIEW BOARD
14. Mesothelioma: is chemotherapy alone a thing of the past?
15. Value of metalloproteinases in predicting COPD in heavy urban smokers
16. A Propensity-Matched Cohort Study of Tocilizumab in Patients With Coronavirus Disease 2019
17. Clinical Outcomes in Critically Ill Coronavirus Disease 2019 Patients: A Unique New York City Public Hospital Experience
18. Supplementary File Table All (excel) from Lower Airway Dysbiosis Affects Lung Cancer Progression
19. Supplementary Table from Lower Airway Dysbiosis Affects Lung Cancer Progression
20. Supplementary Figure All from Lower Airway Dysbiosis Affects Lung Cancer Progression
21. Data from Lower Airway Dysbiosis Affects Lung Cancer Progression
22. Supplementary Figure Legends from Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy
23. Supplementary Methods from Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy
24. Supplemental Tables from Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy
25. Supplementary Table 1 from A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction
26. Supplementary Figure 2 from A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction
27. Supplementary Figure 1 from A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction
28. Supplementary Figure 3 from A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction
29. Supplementary Figures from Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy
30. Local Immunotherapy of Cancer: Innovative Approaches to Harnessing Tumor-Specific Immune Responses
31. High Yield of Bronchoscopic Transparenchymal Nodule Access Real-Time Image-Guided Sampling in a Novel Model of Small Pulmonary Nodules in Canines
32. Gene Therapy for Malignant Pleural Mesothelioma
33. ENVIRONMENTAL EFFECTS OF AIR POLLUTION ON THE LUNG TRANSCRIPTOME IN THE LOWER AIRWAYS FOR PATIENTS WITH LATE-STAGE LUNG CANCER
34. Updates in the diagnosis and treatment of malignant pleural mesothelioma
35. Gene Therapy for Malignant Pleural Mesothelioma
36. Endobronchial Valve Treatment for Prolonged Air Leaks of the Lung: A Case Series
37. Harnessing the Power of the Host: Improving Dendritic Cell Vaccines for Malignant Pleural Mesothelioma
38. Interventional Bronchoscopy in 2015. Removing Endoluminal and Methodological Obstructions
39. Ultrathin Is In: A New Option for Peripheral Pulmonary Nodules
40. Bringing Comfort to Endobronchial Ultrasound Bronchoscopy
41. Management of endobronchial metastasis of colorectal carcinoma
42. Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk
43. sj-pdf-1-aop-10.1177_10600280211028882 – Supplemental material for Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk
44. Gene therapy in interventional pulmonology: Interferon gene delivery with focus on thoracic malignancies
45. Stent-Mediated Gene Delivery for Site-Specific Transgene Administration to the Airway Epithelium and Management of Tracheobronchial Tumors
46. Advances in Pleural Disease Management Including Updated Procedural Coding
47. Feasibility and Safety of Bronchoscopic Transparenchymal Nodule Access in Canines: A New Real-Time Image-Guided Approach to Lung Lesions
48. Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trial
49. Lung Cancer Characteristics in the World Trade Center Environmental Health Center
50. Endoscopic Lung Volume Reduction. An American Perspective
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.